Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHUKRA PHARMA vs WANBURY - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHUKRA PHARMA WANBURY SHUKRA PHARMA/
WANBURY
 
P/E (TTM) x 19.3 20.5 94.3% View Chart
P/BV x 14.1 - - View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 SHUKRA PHARMA   WANBURY
EQUITY SHARE DATA
    SHUKRA PHARMA
Mar-23
WANBURY
Mar-23
SHUKRA PHARMA/
WANBURY
5-Yr Chart
Click to enlarge
High Rs8990 99.1%   
Low Rs1133 33.6%   
Sales per share (Unadj.) Rs53.7152.8 35.1%  
Earnings per share (Unadj.) Rs4.0-3.2 -126.5%  
Cash flow per share (Unadj.) Rs5.70.6 936.9%  
Dividends per share (Unadj.) Rs0.500-  
Avg Dividend yield %1.00-  
Book value per share (Unadj.) Rs23.1-10.5 -219.2%  
Shares outstanding (eoy) m10.9632.71 33.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.90.4 231.8%   
Avg P/E ratio x12.4-19.3 -64.4%  
P/CF ratio (eoy) x8.8100.8 8.7%  
Price / Book Value ratio x2.2-5.8 -37.2%  
Dividend payout %12.40-   
Avg Mkt Cap Rs m5472,004 27.3%   
No. of employees `000NANA-   
Total wages/salary Rs m44810 5.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m5884,996 11.8%  
Other income Rs m1210 118.8%   
Total revenues Rs m6005,007 12.0%   
Gross profit Rs m54225 23.9%  
Depreciation Rs m18124 14.8%   
Interest Rs m3214 1.3%   
Profit before tax Rs m44-103 -43.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m01 32.1%   
Profit after tax Rs m44-104 -42.4%  
Gross profit margin %9.14.5 202.6%  
Effective tax rate %0.8-1.1 -74.8%   
Net profit margin %7.5-2.1 -360.0%  
BALANCE SHEET DATA
Current assets Rs m5311,222 43.4%   
Current liabilities Rs m4253,204 13.3%   
Net working cap to sales %18.0-39.7 -45.3%  
Current ratio x1.20.4 327.4%  
Inventory Days Days04 0.0%  
Debtors Days Days1,873497 377.1%  
Net fixed assets Rs m2191,742 12.6%   
Share capital Rs m39327 12.0%   
"Free" reserves Rs m214-672 -31.8%   
Net worth Rs m253-344 -73.4%   
Long term debt Rs m380-   
Total assets Rs m7502,984 25.1%  
Interest coverage x16.80.5 3,237.5%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.81.7 46.9%   
Return on assets %6.33.7 169.6%  
Return on equity %17.430.2 57.7%  
Return on capital %16.2-32.2 -50.4%  
Exports to sales %058.0 0.0%   
Imports to sales %020.5 0.0%   
Exports (fob) Rs mNA2,899 0.0%   
Imports (cif) Rs mNA1,024 0.0%   
Fx inflow Rs m02,997 0.0%   
Fx outflow Rs m01,072 0.0%   
Net fx Rs m01,925 0.0%   
CASH FLOW
From Operations Rs m32198 16.0%  
From Investments Rs m-44-88 50.1%  
From Financial Activity Rs m49-320 -15.4%  
Net Cashflow Rs m37-210 -17.5%  

Share Holding

Indian Promoters % 51.0 30.6 166.8%  
Foreign collaborators % 0.0 9.2 -  
Indian inst/Mut Fund % 0.1 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 49.0 60.2 81.4%  
Shareholders   10,963 11,616 94.4%  
Pledged promoter(s) holding % 0.0 99.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHUKRA PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on RELISH PHARMA vs WANBURY

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

RELISH PHARMA vs WANBURY Share Price Performance

Period RELISH PHARMA WANBURY S&P BSE HEALTHCARE
1-Day -2.00% 3.07% 1.18%
1-Month 18.32% -12.77% -0.75%
1-Year 528.10% 285.24% 61.82%
3-Year CAGR 229.50% 20.19% 18.16%
5-Year CAGR 114.18% 44.69% 19.79%

* Compound Annual Growth Rate

Here are more details on the RELISH PHARMA share price and the WANBURY share price.

Moving on to shareholding structures...

The promoters of RELISH PHARMA hold a 51.0% stake in the company. In case of WANBURY the stake stands at 39.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of RELISH PHARMA and the shareholding pattern of WANBURY.

Finally, a word on dividends...

In the most recent financial year, RELISH PHARMA paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 12.4%.

WANBURY paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of RELISH PHARMA, and the dividend history of WANBURY.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.